Role of gamma-glutamyl transferase levels in prediction of high cardiovascular risk among patients with non-alcoholic fatty liver disease

KASAPOĞLU B., Turkay C., YALÇIN K. S., Carlioglu A., Koktener A.

INDIAN JOURNAL OF MEDICAL RESEARCH, cilt.143, ss.30-36, 2016 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 143
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4103/0971-5916.178585
  • Dergi Adı: INDIAN JOURNAL OF MEDICAL RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.30-36
  • Anahtar Kelimeler: BMI, cardiovascular disease risk score, Framingham, gamma glutamyl transferase, non-alcoholic fatty liver disease, non-obese, NATURAL-HISTORY, INSULIN-RESISTANCE, HEPATIC STEATOSIS, HEART-DISEASE, MORTALITY, INDIVIDUALS, HOMEOSTASIS, SEVERITY, FIBROSIS, OBESITY
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

Background & objectives: Non-alcoholic fatty liver disease (NAFLD) is an important cause of elevated liver functions. There is evidence showing an association between NAFLD and subclinical atherosclerosis independent of traditional risk factors. We undertook this retrospective study to determine the association of Framingham cardiovascular risk scoring system with liver function tests and inflammatory markers and to find the role of liver function tests in determination of CVD risk among non-obese and nondiabetic subjects with non-alcoholic fatty liver disease.